CAPDM welcomes Juno Pharmaceuticals Canada

Juno Pharmaceuticals Canada is a specialty pharmaceutical company that focuses on branded, complex, biosimilar, and high value generics that bring meaningful savings to the Canadian Healthcare industry.

We work with trusted partners to co-develop novel drug delivery mechanisms that satisfy untapped market demand, first to market generic products, and execute on patent challenge strategies.

Juno’s portfolio consists of both branded and generic drug assets in multiple presentation forms including injectable drugs (vials, amps, & pre-filled syringes), ophthalmic products, oral dose tablets and capsules, prescription dermatology topicals, and other unique dosage forms.
Our team has deep roots into the Canadian hospital space, retail pharmacy market, specialty channels, and a robust B2B platform. In addition, Juno Canada has recently embarked with product sourcing in the animal health space and remain focused on opening new delivery channels and customer groups to facilitate supply for Canadian patients.

Juno is proud to supply 8 molecules deemed medically necessary by the World Health Organization on their critically essential medications list, and we are actively pursuing export opportunities to countries in need of our critical medications. In addition, Juno is working diligently with our global manufacturing network to bring products on the Health Canada Tier 3 shortage list to Canadians in need.

Juno Pharmaceuticals Canada is passionate about sourcing, developing, and delivering life saving medications that advance the healthcare of Canadians.

For more information please visit: www.junopharm.ca